Betnovate Scalp Application Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Betamethasone valerate

Indications/Uses

Steroid-responsive scalp dermatoses (eg, psoriasis, seborrhea capitis, inflammation associated w/ severe dandruff).

Click to view Betnovate Scalp Application detailed prescribing information

Dosage/Direction for Use

Adult, elderly & childn >1 yr Apply a small quantity to the scalp at night & morning until improvement is noticeable. May then be applied once daily or less frequently to sustain improvement.

Click to view Betnovate Scalp Application detailed prescribing information

Overdosage

View Betnovate Scalp Application overdosage for action to be taken in the event of an overdose.

Contraindications

Scalp infection. Dermatoses including dermatitis in infants <1 yr.

Click to view Betnovate Scalp Application detailed prescribing information

Special Precautions

Patients w/ history of local hypersensitivity to corticosteroids. Risk factors that may increase systemic absorption of topical steroids. W/draw gradually if manifestations of hypercortisolism (Cushing's syndrome) & reversible hypothalamic-pituitary-adrenal axis suppression occur. Avoid abrupt w/drawal. Reports of visual disturbance. Risk of bacterial infection w/ occlusion. Reports of rebound relapses, development of tolerances, risk of generalised pustular psoriasis & development of local or systemic toxicity when used in psoriasis. Avoid smoking or being near an open flame during application & immediately after use. Patients w/ renal or hepatic impairment. Pregnancy & lactation. Long-term continuous therapy should be avoided where possible in infants & childn <12 yr.

Click to view Betnovate Scalp Application detailed prescribing information

Use In Pregnancy & Lactation

Click to view Betnovate Scalp Application detailed prescribing information

Adverse Reactions

Pruritus, local skin burning/pain.

Click to view Betnovate Scalp Application detailed prescribing information

Drug Interactions

Increased systemic exposure w/ CYP3A4 inhibitors eg, ritonavir, itraconazole.

Click to view Betnovate Scalp Application detailed prescribing information

Storage

View Betnovate Scalp Application storage conditions for details to ensure optimal shelf-life.

Description

View Betnovate Scalp Application description for details of the chemical structure and excipients (inactive components).

Action

View Betnovate Scalp Application mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Topical Corticosteroids

ATC Classification

D07AC01 - betamethasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Betnovate Scalp Application 1 mg/mL

Packing/Price

30 mL x 1's

Betnovate Scalp Application

betamethasone

Manufacturer:

Aspen Bad Oldesloe

Distributor:

GlaxoSmithKline